Karin Jordan Selected Research

netupitant

1/2022	Netupitant-palonosetron (NEPA) for Preventing Chemotherapy-induced Nausea and Vomiting: From Clinical Trials to Daily Practice.
11/2021	Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis.
1/2019	Fixed combination of oral NEPA (netupitant-palonosetron) for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double-blind phase III studies.
1/2018	Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based Chemotherapy.
2/2016	Antiemetics: American Society of Clinical Oncology Focused Guideline Update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karin Jordan Research Topics

Disease

46	Vomiting 12/2023 - 05/2004
43	Nausea 12/2023 - 05/2004
30	Neoplasms (Cancer) 12/2023 - 05/2004
8	Multiple Myeloma 01/2023 - 02/2014
4	Infections 01/2023 - 07/2008
4	Diarrhea 07/2017 - 05/2004
3	Disease Progression 12/2017 - 04/2008
3	Neoplasm Metastasis (Metastasis) 12/2017 - 12/2009
3	Peripheral Nervous System Diseases (PNS Diseases) 07/2017 - 05/2004
3	Breast Neoplasms (Breast Cancer) 07/2017 - 04/2010
3	Neutropenia 07/2017 - 06/2015
2	Thrombocytopenia (Thrombopenia) 01/2023 - 06/2015
2	Leukopenia 01/2022 - 07/2021
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2015
2	Febrile Neutropenia 07/2021 - 07/2017
2	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2017
2	Myasthenia Gravis 01/2019 - 04/2006
2	Pain (Aches) 12/2017 - 04/2014
2	Anemia 07/2017 - 06/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 05/2004
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2017 - 05/2004
2	Anorexia 06/2015 - 12/2009
2	Thrombosis (Thrombus) 01/2012 - 09/2008
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023
1	Hemorrhage 01/2023
1	Opportunistic Infections (Opportunistic Infection) 01/2023
1	Cachexia 01/2022
1	Glioma (Gliomas) 01/2022
1	Paramyxoviridae Infections (Parainfluenza) 01/2022
1	Coinfection 01/2022
1	Body Weight (Weight, Body) 04/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Polyneuropathies (Polyneuropathy) 04/2019
1	Death (Near-Death Experience) 11/2018
1	Lymphoma (Lymphomas) 07/2018
1	Prostatic Neoplasms (Prostate Cancer) 12/2017
1	Osteonecrosis (Kienbock's Disease) 12/2017
1	Stomatitis 07/2017

Drug/Important Bio-Agent (IBA)

27	AntiemeticsIBA 12/2023 - 01/2005
14	Dexamethasone (Maxidex)FDA LinkGeneric 09/2021 - 01/2005
10	AnthracyclinesIBA 01/2021 - 04/2009
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 04/2010
8	Neurokinin-1 Receptor AntagonistsIBA 01/2021 - 04/2016
6	Antineoplastic Agents (Antineoplastics)IBA 12/2023 - 03/2011
6	EmeticsIBA 12/2023 - 05/2009
5	Palonosetron (Aloxi)FDA Link 01/2022 - 02/2016
5	netupitantIBA 01/2022 - 02/2016
5	Granisetron (Kytril)FDA LinkGeneric 11/2021 - 01/2005
5	Aprepitant (Emend)FDA Link 11/2021 - 02/2006
5	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2021 - 01/2005
5	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 08/2016
5	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 02/2006
4	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 02/2007
4	fosaprepitant FDA Link 11/2021 - 01/2018
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2017 - 05/2004
3	Rituximab (Mabthera)FDA Link 11/2023 - 03/2005
3	rolapitantIBA 11/2021 - 08/2016
3	PlatinumIBA 01/2020 - 06/2015
3	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 02/2007
3	Fluorouracil (Carac)FDA LinkGeneric 03/2014 - 05/2004
2	Serotonin AntagonistsIBA 12/2023 - 01/2017
2	Ondansetron (Zofran)FDA LinkGeneric 11/2021 - 09/2020
2	Drug CombinationsIBA 11/2021 - 04/2011
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2021 - 07/2017
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2019
2	Substance PIBA 01/2017 - 02/2007
2	Bevacizumab (Avastin)FDA Link 01/2012 - 12/2009
2	Irinotecan (Camptosar)FDA LinkGeneric 04/2011 - 05/2004
2	Dopamine AntagonistsIBA 03/2011 - 02/2007
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023
1	APTIBA 01/2023
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	SteroidsIBA 01/2022
1	casopitantIBA 11/2021
1	ramosetron (Nasea)IBA 11/2021
1	carfilzomibIBA 09/2021
1	Lenalidomide (CC 5013)FDA Link 09/2021
1	Melphalan (Alkeran)FDA LinkGeneric 04/2020
1	pembrolizumabIBA 01/2020
1	NivolumabIBA 07/2018
1	Diphosphonates (Bisphosphonates)IBA 12/2017
1	Analgesics (Analgesic Drugs)IBA 12/2017
1	Olanzapine (Zyprexa)FDA Link 10/2017
1	Dihydrotachysterol (AT 10)IBA 07/2017

Therapy/Procedure

46	Drug Therapy (Chemotherapy) 12/2023 - 01/2005
18	Therapeutics 01/2023 - 05/2004
10	Radiotherapy 12/2023 - 01/2010
7	Stem Cell Transplantation 01/2023 - 07/2018
4	Catheters 01/2012 - 05/2006
2	Chemoradiotherapy 12/2023 - 08/2015
2	Immunotherapy 01/2020 - 01/2019
2	Palliative Care (Palliative Therapy) 11/2018 - 07/2017
2	Intravenous Administration 04/2009 - 02/2005
2	Vascular Access Devices (Arterial Line) 09/2008 - 05/2006
1	Secondary Prevention 01/2023
1	Hematopoietic Stem Cell Transplantation 01/2023
1	Hematopoietic Stem Cell Mobilization 10/2021
1	Antibiotic Prophylaxis 07/2021
1	Transplantation 01/2020